Dreamm-5 Platform Trial: Belantamab Mafodotin (Belamaf) in Combination with Four Different Novel Agents in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Resource Type
Abstract
Authors
Richardson, Paul G. ; Nooka, Ajay ; Quach, Hang ; Trudel, Suzanne ; Routledge, David ; Song, Kevin ; Nahi, Hareth ; Paul, Sofia ; Khan, Josephine ; Brouch, Maria ; Ferron-Brady, Geraldine ; Yeakey, Anne ; Shelton, Chris ; Montes de Oca, Rocio ; Smith, L. Mary ; Im, Ellie ; Ahlers, Christoph M ; Paul, Elaine M ; Holkova, Beata ; Gupta, Ira ; Kremer, Brandon E. ; Rodriguez-Otero, Paula
Source
In Blood 5 November 2020 136 Supplement 1:1-2
Subject
Language
ISSN
0006-4971